Literature DB >> 27091931

Burkholderia pseudomallei Capsule Exacerbates Respiratory Melioidosis but Does Not Afford Protection against Antimicrobial Signaling or Bacterial Killing in Human Olfactory Ensheathing Cells.

Samantha J Dando1, Deepak S Ipe1,2, Michael Batzloff1, Matthew J Sullivan2, David K Crossman3, Michael Crowley3, Emily Strong1, Stephanie Kyan1, Sophie Y Leclercq2,4, Jenny A K Ekberg5,6, James St John6, Ifor R Beacham7, Glen C Ulett7,2,8.   

Abstract

Melioidosis, caused by the bacterium Burkholderia pseudomallei, is an often severe infection that regularly involves respiratory disease following inhalation exposure. Intranasal (i.n.) inoculation of mice represents an experimental approach used to study the contributions of bacterial capsular polysaccharide I (CPS I) to virulence during acute disease. We used aerosol delivery of B. pseudomallei to establish respiratory infection in mice and studied CPS I in the context of innate immune responses. CPS I improved B. pseudomallei survival in vivo and triggered multiple cytokine responses, neutrophil infiltration, and acute inflammatory histopathology in the spleen, liver, nasal-associated lymphoid tissue, and olfactory mucosa (OM). To further explore the role of the OM response to B. pseudomallei infection, we infected human olfactory ensheathing cells (OECs) in vitro and measured bacterial invasion and the cytokine responses induced following infection. Human OECs killed >90% of the B. pseudomallei in a CPS I-independent manner and exhibited an antibacterial cytokine response comprising granulocyte colony-stimulating factor, tumor necrosis factor alpha, and several regulatory cytokines. In-depth genome-wide transcriptomic profiling of the OEC response by RNA-Seq revealed a network of signaling pathways activated in OECs following infection involving a novel group of 378 genes that encode biological pathways controlling cellular movement, inflammation, immunological disease, and molecular transport. This represents the first antimicrobial program to be described in human OECs and establishes the extensive transcriptional defense network accessible in these cells. Collectively, these findings show a role for CPS I in B. pseudomallei survival in vivo following inhalation infection and the antibacterial signaling network that exists in human OM and OECs.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27091931      PMCID: PMC4936350          DOI: 10.1128/IAI.01546-15

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  80 in total

Review 1.  Interaction between Burkholderia pseudomallei and the host immune response: sleeping with the enemy?

Authors:  Yunn-Hwen Gan
Journal:  J Infect Dis       Date:  2005-10-07       Impact factor: 5.226

2.  Olfactory ensheathing cells: the primary innate immunocytes in the olfactory pathway to engulf apoptotic olfactory nerve debris.

Authors:  Zhida Su; Jingjing Chen; Yang Qiu; Yimin Yuan; Feng Zhu; Yanling Zhu; Xiujie Liu; Yingyan Pu; Cheng He
Journal:  Glia       Date:  2013-01-22       Impact factor: 7.452

Review 3.  Management of melioidosis.

Authors:  Vanaporn Wuthiekanun; Sharon J Peacock
Journal:  Expert Rev Anti Infect Ther       Date:  2006-06       Impact factor: 5.091

4.  Phagocytosis of bacteria by olfactory ensheathing cells and Schwann cells.

Authors:  P Panni; I A Ferguson; I Beacham; A Mackay-Sim; J A K Ekberg; J A St John
Journal:  Neurosci Lett       Date:  2013-02-14       Impact factor: 3.046

5.  The Burkholderia pseudomallei Δasd mutant exhibits attenuated intracellular infectivity and imparts protection against acute inhalation melioidosis in mice.

Authors:  Michael H Norris; Katie L Propst; Yun Kang; Steven W Dow; Herbert P Schweizer; Tung T Hoang
Journal:  Infect Immun       Date:  2011-08-01       Impact factor: 3.441

Review 6.  Endemic melioidosis in tropical northern Australia: a 10-year prospective study and review of the literature.

Authors:  B J Currie; D A Fisher; D M Howard; J N Burrow; D Lo; S Selva-Nayagam; N M Anstey; S E Huffam; P L Snelling; P J Marks; D P Stephens; G D Lum; S P Jacups; V L Krause
Journal:  Clin Infect Dis       Date:  2000-10-25       Impact factor: 9.079

7.  Uropathogenic Escherichia coli Engages CD14-Dependent Signaling to Enable Bladder-Macrophage-Dependent Control of Acute Urinary Tract Infection.

Authors:  Alison J Carey; Matthew J Sullivan; Benjamin L Duell; David K Crossman; Debasish Chattopadhyay; Andrew J Brooks; Chee K Tan; Michael Crowley; Matthew J Sweet; Mark A Schembri; Glen C Ulett
Journal:  J Infect Dis       Date:  2015-08-30       Impact factor: 5.226

Review 8.  Pulmonary melioidosis.

Authors:  M Ip; L G Osterberg; P Y Chau; T A Raffin
Journal:  Chest       Date:  1995-11       Impact factor: 9.410

9.  Toll-like receptor 2 impairs host defense in gram-negative sepsis caused by Burkholderia pseudomallei (Melioidosis).

Authors:  W Joost Wiersinga; Catharina W Wieland; Mark C Dessing; Narisara Chantratita; Allen C Cheng; Direk Limmathurotsakul; Wirongrong Chierakul; Masja Leendertse; Sandrine Florquin; Alex F de Vos; Nicholas White; Arjen M Dondorp; Nicholas P Day; Sharon J Peacock; Tom van der Poll
Journal:  PLoS Med       Date:  2007-07-31       Impact factor: 11.069

10.  Type 3 secretion system cluster 3 is a critical virulence determinant for lung-specific melioidosis.

Authors:  Maria G Gutierrez; Tia L Pfeffer; Jonathan M Warawa
Journal:  PLoS Negl Trop Dis       Date:  2015-01-08
View more
  7 in total

Review 1.  The Immunological Roles of Olfactory Ensheathing Cells in the Treatment of Spinal Cord Injury.

Authors:  Yizhen Jiang; Jianbin Guo; Xiangwen Tang; Xiaohui Wang; Dingjun Hao; Hao Yang
Journal:  Front Immunol       Date:  2022-05-20       Impact factor: 8.786

2.  Novel factor in olfactory ensheathing cell-astrocyte crosstalk: Anti-inflammatory protein α-crystallin B.

Authors:  Aybike Saglam; Anne L Calof; Susan Wray
Journal:  Glia       Date:  2020-12-12       Impact factor: 8.073

3.  Chlamydia muridarum Can Invade the Central Nervous System via the Olfactory and Trigeminal Nerves and Infect Peripheral Nerve Glial Cells.

Authors:  Lynn Nazareth; Heidi Walkden; Anu Chacko; Ali Delbaz; Todd Shelper; Charles W Armitage; Ronak Reshamwala; Logan K Trim; James A St John; Kenneth W Beagley; Jenny A K Ekberg
Journal:  Front Cell Infect Microbiol       Date:  2021-01-08       Impact factor: 5.293

4.  Chlamydia pneumoniae can infect the central nervous system via the olfactory and trigeminal nerves and contributes to Alzheimer's disease risk.

Authors:  Anu Chacko; Ali Delbaz; Heidi Walkden; Souptik Basu; Charles W Armitage; Tanja Eindorf; Logan K Trim; Edith Miller; Nicholas P West; James A St John; Kenneth W Beagley; Jenny A K Ekberg
Journal:  Sci Rep       Date:  2022-02-17       Impact factor: 4.379

5.  Streptococcus agalactiae Infects Glial Cells and Invades the Central Nervous System via the Olfactory and Trigeminal Nerves.

Authors:  Anu Chacko; Ali Delbaz; Indra N Choudhury; Tanja Eindorf; Megha Shah; Christopher Godfrey; Matthew J Sullivan; James A St John; Glen C Ulett; Jenny A K Ekberg
Journal:  Front Cell Infect Microbiol       Date:  2022-02-24       Impact factor: 5.293

6.  Burkholderia pseudomallei invades the olfactory nerve and bulb after epithelial injury in mice and causes the formation of multinucleated giant glial cells in vitro.

Authors:  Heidi Walkden; Ali Delbaz; Lynn Nazareth; Michael Batzloff; Todd Shelper; Ifor R Beacham; Anu Chacko; Megha Shah; Kenneth W Beagley; Johana Tello Velasquez; James A St John; Jenny A K Ekberg
Journal:  PLoS Negl Trop Dis       Date:  2020-01-24

7.  Burkholderia pseudomallei pathogenesis in human skin fibroblasts: A Bsa type III secretion system is involved in the invasion, multinucleated giant cell formation, and cellular damage.

Authors:  Anek Kaewpan; Taksaon Duangurai; Amporn Rungruengkitkun; Watcharamat Muangkaew; Tapanee Kanjanapruthipong; Niramol Jitprasutwit; Sumate Ampawong; Passanesh Sukphopetch; Narisara Chantratita; Pornpan Pumirat
Journal:  PLoS One       Date:  2022-02-03       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.